Created with Sketch.

Safety and efficacy of Nutriterra® confirmed

Nutriterra, A Novel Plant-Based Source of Total Omega-3 Significantly Improves Blood Profiles in Human Clinical Trial

Nuseed Nutritional US Inc., has completed a human clinical trial, confirming the safety and efficacy of Nutriterra as a novel plant-based source of total omega-3 nutrition.

Results from the trial indicated patients taking Nutriterra Total Omega-3 dietary supplements readily absorbed the oil’s long-chain omega-3s, including DHA+EPA, and short-chain ALA, which were incorporated into blood lipids, including red blood cells.  The mid and high doses studied significantly improved levels of omega-3, as measured by the OmegaScoreTM and the Omega-3 Index, leading to reduced cardiovascular and cognitive risks.  A white paper detailing these findings will be featured in Natural Products Insider and available in its entirety at NutriterraOmega3.com.

Nutriterra is the world’s first land-based source of total omega-3 nutrients, produced by Nuseed to deliver the benefits of microalgae via its proprietary Omega-3 Canola. Nutriterra offers a much-needed alternative to marine omega-3s to bridge the gap between growing consumer demand and finite ocean resources.   

“The growing demand for plant-based omega-3 nutrients goes well beyond the vegetarian market. Consumers are seeking better tasting options, and Nutriterra provides a milder sensory experience than marine oils.  Consumers are also deeply concerned about ocean health. Nuseed’s sophisticated technology has the potential to double the world’s supply of DHA without depleting ocean resources,” says Benita Boettner, Nuseed Nutritional General Manager.

Nuseed partnered with Nutrasource in Canada to design and conduct a 16-week randomized, double-blind, placebo-controlled clinical trial. Healthy adult subjects consumed one of three doses of the product, or a placebo, for a period of 16 weeks.  Here are some of the key findings:

  • Nutriterra exhibited a good safety and tolerability profile
  • Omega-3 DHA, EPA and ALA from Nutriterra is absorbed readily and incorporated into blood lipids
  • Nutriterra significantly improved levels of omega-3, as measured by the OmegaScoreTM and the Omega-3 Index, leading to reduced risk of:
    • all-cause mortality
    • total cardiovascular events
    • cognitive deterioration associated with aging

In addition to these findings, the white paper highlights Nuseed’s innovation in developing this technology and the positive environmental impact it delivers. By producing a plant-based source of long-chain omega-3 fatty acids, Nutriterra reduces pressure on marine resources to supply these essential nutrients.

Download the whitepaper